You are here: Industry Insights > CDMO

News List

Particle Sciences to open new commercial facility cphi-online
November 14, 2018
Particle Sciences, a Lubrizol LifeSciences company and US-based pharmaceutical CDMO, is opening a new commercial drug product manufacturing facility at the end of Q4 2018.
Recro Pharma expands CDMO business in Georgia fiercepharma
November 08, 2018
Recro Pharma was granted a March 2019 PDUFA date for its non-opioid pain drug after providing the FDA with additional data and answering manufacturing questions raised in a complete response letter.
Generics, small molecule injectables to drive growth, says Piramal biospectrumasia
October 23, 2018
Small molecule injectables are likely to expand at a faster rate'Singapore:India's Piramal Enterprises' Phar
ADC Market to Grow to $4B contractpharma
October 10, 2018
A new analysis in the CPhI Annual Report estimates the increase in growth by 2023
Vetter Grants Award for Novel Idea at Injection 2.0 biospectrumasia
September 29, 2018
On September 25, the four groups presented their ideas in short presentations at the company’s Ravensburg Vetter West site
CDMO Ology Bioservices Wins $8.4m DoD Award contractpharma
August 21, 2018
a biologics contract development and manufacturing organization (CDMO), was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS......
Cambrex enters growing finished dosage form market cphi-online
July 26, 2018
Acquisition of Halo Pharma adds competencies including developing and manufacturing products for pediatric indications.
Oncobiologics Enters First CDMO Contract contractpharma
June 19, 2018
Oncobiologics has entered into a Master Services Agreement (MSA) with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform-based contract development and manufacturing
WuXi Biologics to build new CDMO plant biospectrumasia
May 18, 2018
WuXi Biologics is planning to build an integrated biologics development, clinical and commercial manufacturing centre in the city of Shijiazhuang, capital of Hebei province in northern China.
Ardena acquisition strengthens API offering cphi-online
May 10, 2018
CDMO Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page